The DNA-cleaving mechanism of VP-16 (etoposide) Cu(II)-complexes is driven by DNA binding affinity and hydroxyl radical generation.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Anshel et al. (1996) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: